Meridian
Pharma & biotech signals

Signals

Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.

Showing 81–100 of 631 signals

Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment

CompaniesSilo PharmaAssetsSPC-15Diseasespost-traumatic stress disorder (PTSD)
2 sources — primary and 1 also reporting

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CompaniesZenas BioPharma
3 sources — primary and 2 also reporting

Acquisition of Own Shares

CompaniesLakefront Biotherapeutics

Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald

CompaniesEikon TherapeuticsCantor FitzgeraldUniversity of Texas MD Anderson Cancer CenterDiseasesbreast cancerovarian cancerprostate cancerpancreatic cancer
2 sources — primary and 1 also reporting